Dynamic Multi Frequency Pressure Pulse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Respinova Granted FDA 510(k) Clearance for Pulsehaler™
USA - English
Share this article
Share this article
HERZLIYA, Israel, April 6, 2021 /PRNewswire/ Respinova Ltd. is pleased to announce it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Pulsehaler™. Pulsehaler™ is an innovative device that facilitates the opening of airways and clearance of secretions in patients with respiratory diseases.
Despite the available pharma treatments, patients with COPD, Asthma, CF and other respiratory diseases unfortunately still suffer from poor quality of life, commented Professor Raphael Breuer, MD, former Head of the Institute of Pulmonology at Hadassah University Medical Center. Pulsehaler™ brings a novel approach that will help patients with these conditions open their airways, which should improve their symptoms significantly , he added. ....

Tel Aviv , Cliff Ansel , Raphael Breuer , Drug Administration , Prnewswire Respinova Ltd , Respinova Ltd , Professor Raphael Breuer , Hadassah University Medical , Dynamic Multi Frequency Pressure Pulse , European Horizon , தொலைபேசி அவிவ் , குன்றின் அன்செல் , ரபேல் ப்ரூவர் , ப்ரொஃபெஸர் ரபேல் ப்ரூவர் , ஹடாஸா பல்கலைக்கழகம் மருத்துவ , மாறும் பல அதிர்வெண் ப்ரெஶர் துடிப்பு , ஐரோப்பிய அடிவானம் ,